8622 Share Price Performance
HK$0.49
0.29 (141.38%)
Price HK$0.49
Share PriceHK$0.49
Huakang Biomedical Holdings Company Limited Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
8622 Community Narratives
There are no narratives available yet.
There are no community narratives available.
Snowflake Analysis
Huakang Biomedical Holdings Company Limited Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
- -0.0095
- 67.90%
- -18.42%
- 5.4%
About 8622
- Founded
- 1992
- Employees
- 98
- CEO
- WebsiteView website
Huakang Biomedical Holdings Company Limited, an investment holding company, engages in the research, production, and sale of male fertility in-vitro diagnostic (IVD) reagents in the People's Republic of China. The company provides biological reagents, including male fertility IVD reagents, parasite antibody detection reagents, and Epstein-Barr virus antibody detection reagent; and auxiliary reproductive supplies and equipment. The company sells its products directly to hospitals and medical institutions, as well as to distributors. Huakang Biomedical Holdings Company Limited was founded in 1992 and is based in Tsim Sha Tsui, Hong Kong.
